
Nathan J. Milakovich
Examiner (ID: 7093, Phone: (571)270-3087 , Office: P/2848 )
| Most Active Art Unit | 2848 |
| Art Unit(s) | 2835, 4134, 2848, 2847 |
| Total Applications | 953 |
| Issued Applications | 727 |
| Pending Applications | 69 |
| Abandoned Applications | 167 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5070205
[patent_doc_number] => 20070191307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Nanosized Carotenoid Cyclodextrin Complexes'
[patent_app_type] => utility
[patent_app_number] => 11/538766
[patent_app_country] => US
[patent_app_date] => 2006-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3317
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191307.pdf
[firstpage_image] =>[orig_patent_app_number] => 11538766
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/538766 | Nanosized carotenoid cyclodextrin complexes | Oct 3, 2006 | Issued |
Array
(
[id] => 5101792
[patent_doc_number] => 20070185054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Novel parenteral carbamazepine formulation'
[patent_app_type] => utility
[patent_app_number] => 11/542520
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8628
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542520
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542520 | Novel parenteral carbamazepine formulation | Oct 1, 2006 | Abandoned |
Array
(
[id] => 5101776
[patent_doc_number] => 20070185038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Regulation of mammalian keratinous tissue using skin care actives'
[patent_app_type] => utility
[patent_app_number] => 11/541324
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10925
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185038.pdf
[firstpage_image] =>[orig_patent_app_number] => 11541324
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/541324 | Regulation of mammalian keratinous tissue using skin care actives | Sep 28, 2006 | Abandoned |
Array
(
[id] => 4939404
[patent_doc_number] => 20080076723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Inhibition of cathepsin K activity and the treatment and prevention of disease'
[patent_app_type] => utility
[patent_app_number] => 11/527725
[patent_app_country] => US
[patent_app_date] => 2006-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6414
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076723.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527725
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527725 | Inhibition of cathepsin K activity and the treatment and prevention of disease | Sep 26, 2006 | Abandoned |
Array
(
[id] => 4840514
[patent_doc_number] => 20080281000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Hydrophobic Polysaccharide Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/065846
[patent_app_country] => US
[patent_app_date] => 2006-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9248
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20080281000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065846
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065846 | Hydrophobic Polysaccharide Derivatives | Sep 5, 2006 | Abandoned |
Array
(
[id] => 5070204
[patent_doc_number] => 20070191306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'FACTOR Xa INHIBITOR FORMULATION AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 11/464519
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5262
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191306.pdf
[firstpage_image] =>[orig_patent_app_number] => 11464519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/464519 | FACTOR Xa INHIBITOR FORMULATION AND METHOD | Aug 14, 2006 | Abandoned |
Array
(
[id] => 5101790
[patent_doc_number] => 20070185052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Use of lipid conjugates in cystic fibrosis and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 11/496728
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18887
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185052.pdf
[firstpage_image] =>[orig_patent_app_number] => 11496728
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/496728 | Use of lipid conjugates in cystic fibrosis and applications thereof | Jul 31, 2006 | Abandoned |
| 11/494898 | Materials and methods for modulating arginine metabolism | Jul 27, 2006 | Abandoned |
Array
(
[id] => 5338073
[patent_doc_number] => 20090054537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'THERAPEUTIC PROTOCOLS USING HYALURONAN'
[patent_app_type] => utility
[patent_app_number] => 11/996733
[patent_app_country] => US
[patent_app_date] => 2006-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22691
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054537.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996733
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996733 | Therapeutic protocols using hyaluronan | Jul 26, 2006 | Issued |
Array
(
[id] => 4676849
[patent_doc_number] => 20080214480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae'
[patent_app_type] => utility
[patent_app_number] => 11/996261
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6241
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214480.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996261 | Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae | Jul 20, 2006 | Abandoned |
Array
(
[id] => 4991430
[patent_doc_number] => 20070006774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Ionic liquid reconstituted cellulose composites as solid support matrices'
[patent_app_type] => utility
[patent_app_number] => 11/475630
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24657
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20070006774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11475630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/475630 | Ionic liquid reconstituted cellulose composites as solid support matrices | Jun 26, 2006 | Abandoned |
Array
(
[id] => 4779664
[patent_doc_number] => 20080287662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Balanites Aegyptiaca Saponins and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/993899
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17590
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287662.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993899 | Balanites Aegyptiaca Saponins and Uses Thereof | Jun 21, 2006 | Abandoned |
Array
(
[id] => 4995115
[patent_doc_number] => 20070010460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Multiple sclerosis therapy and diagnosis'
[patent_app_type] => utility
[patent_app_number] => 11/472554
[patent_app_country] => US
[patent_app_date] => 2006-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7830
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20070010460.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472554 | Multiple sclerosis therapy and diagnosis | Jun 21, 2006 | Abandoned |
Array
(
[id] => 5688963
[patent_doc_number] => 20060287278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Method for improving water solubility of chitosan'
[patent_app_type] => utility
[patent_app_number] => 11/472236
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4187
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472236 | Method for improving water solubility of chitosan | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5231350
[patent_doc_number] => 20070293458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Prevention of nuclear, solar, and other radiation-induced tissue damage'
[patent_app_type] => utility
[patent_app_number] => 11/453843
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21911
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293458.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453843 | Prevention of nuclear, solar, and other radiation-induced tissue damage | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5575953
[patent_doc_number] => 20090143315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Salix extract, its use and formulations containing it'
[patent_app_type] => utility
[patent_app_number] => 11/988586
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2653
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988586 | Salix extract, its use and formulations containing it | Jun 13, 2006 | Abandoned |
Array
(
[id] => 4887584
[patent_doc_number] => 20080261916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Synergistic Prebiotic Compositions'
[patent_app_type] => utility
[patent_app_number] => 11/917236
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4791
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261916.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917236 | Synergistic Prebiotic Compositions | Jun 11, 2006 | Abandoned |
Array
(
[id] => 8386170
[patent_doc_number] => 08263565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-11
[patent_title] => 'Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/443271
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9473
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11443271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443271 | Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same | May 30, 2006 | Issued |
Array
(
[id] => 6097433
[patent_doc_number] => 20110003744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Glycopegylated Erythropoietin Formulations'
[patent_app_type] => utility
[patent_app_number] => 11/914104
[patent_app_country] => US
[patent_app_date] => 2006-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 36046
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914104 | Glycopegylated Erythropoietin Formulations | May 24, 2006 | Abandoned |
Array
(
[id] => 4808190
[patent_doc_number] => 20080171768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Pharmaceutical Composition Containing An Anti Parasitic Agent And Active Ingredient Selected From Carveol, Thymol, Eugenol, Borneol, Carvacrol, Alpha-Ionone, Or Beta-Ionone'
[patent_app_type] => utility
[patent_app_number] => 11/914019
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4801
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914019 | Pharmaceutical Composition Containing An Anti Parasitic Agent And Active Ingredient Selected From Carveol, Thymol, Eugenol, Borneol, Carvacrol, Alpha-Ionone, Or Beta-Ionone | May 14, 2006 | Abandoned |